Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
14 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Talzenna“
Suchtreffer
Begriffe & Kennungen
Talzenna · 4.8 · 9 Table 4. Adverse reactions based on pooled dataset from 8 studies (N=1 088) System organ class All grades Gr
Eintrag öffnenTalzenna · 4.8 · Description of selected adverse reactions
Eintrag öffnenTalzenna · 4.8 · Dose interruptions of Talzenna due to adverse reactions occurred in 62.1% of patients with mCRPC receiving Tal
Eintrag öffnenTalzenna · 4.8 · In monotherapy studies (1 mg/day population), the most frequent myelosuppression-related adverse events associ
Eintrag öffnenTalzenna · 4.8 · In patients with mCRPC treated with talazoparib in combination with enzalutamide, anaemia led to talazoparib d
Eintrag öffnenTalzenna · 4.8 · Myelosuppression Myelosuppression-related adverse reactions of anaemia, neutropenia and thrombocytopenia were
Eintrag öffnenTalzenna · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenTalzenna · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenTalzenna · 4.8 · Summary of the safety profile
Eintrag öffnenTalzenna · 4.8 · Table 4 summarises adverse reactions based on pooled dataset listed by system organ class, and frequency categ
Eintrag öffnenTalzenna · 4.8 · Table 4. Adverse reactions based on pooled dataset from 8 studies (N=1 088) System organ class All grades Grad
Eintrag öffnenTalzenna · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenTalzenna · 4.8 · The most common (≥ 20%) adverse reactions in patients receiving talazoparib in these clinical studies were ana
Eintrag öffnenTalzenna · 4.8 · The overall safety profile of Talzenna is based on pooled data from 1 088 patients, including 690 patients who
Eintrag öffnen